SMS Pharmaceuticals Limited — Updates, 26-12-2025: General Updates
26-12-2025 | 06:40 pm
26-12-2025 | 06:40 pm
SMS Pharma invested ₹3.99 Cr in its subsidiary, SMS Peptides, to fund R&D machinery. This increases its stake to 99.99% in the pharma unit, currently in the implementation stage.
No comments yet. Be the first to comment!
